Clarity Financial LLC Trims Holdings in CVS Health Co. (NYSE:CVS)

Clarity Financial LLC decreased its holdings in CVS Health Co. (NYSE:CVSFree Report) by 94.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,285 shares of the pharmacy operator’s stock after selling 187,389 shares during the period. Clarity Financial LLC’s holdings in CVS Health were worth $812,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Cantor Fitzgerald Investment Advisor L.P grew its stake in CVS Health by 92.9% in the first quarter. Cantor Fitzgerald Investment Advisor L.P now owns 377,875 shares of the pharmacy operator’s stock valued at $38,245,000 after purchasing an additional 181,966 shares during the last quarter. United Bank boosted its holdings in CVS Health by 7.2% in the first quarter. United Bank now owns 18,658 shares of the pharmacy operator’s stock worth $1,888,000 after acquiring an additional 1,260 shares in the last quarter. Loomis Sayles & Co. L P boosted its holdings in CVS Health by 4,063.8% in the first quarter. Loomis Sayles & Co. L P now owns 12,075 shares of the pharmacy operator’s stock worth $1,222,000 after acquiring an additional 11,785 shares in the last quarter. Zions Bancorporation N.A. boosted its holdings in CVS Health by 116.9% in the first quarter. Zions Bancorporation N.A. now owns 2,572 shares of the pharmacy operator’s stock worth $260,000 after acquiring an additional 1,386 shares in the last quarter. Finally, Ergoteles LLC acquired a new stake in CVS Health in the first quarter worth about $1,551,000. Hedge funds and other institutional investors own 75.99% of the company’s stock.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.25% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Royal Bank of Canada lowered their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. HSBC started coverage on CVS Health in a report on Friday, December 22nd. They set a “buy” rating and a $94.00 target price for the company. Barclays started coverage on CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 target price for the company. Finally, Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $90.21.

Read Our Latest Analysis on CVS

CVS Health Price Performance

Shares of CVS traded down $0.71 during trading hours on Thursday, hitting $78.27. 7,524,159 shares of the stock were exchanged, compared to its average volume of 11,417,673. The stock’s 50-day moving average price is $75.50 and its two-hundred day moving average price is $73.00. The company has a market cap of $98.50 billion, a price-to-earnings ratio of 12.12, a price-to-earnings-growth ratio of 1.03 and a beta of 0.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. CVS Health Co. has a 12-month low of $64.41 and a 12-month high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last released its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The company had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.99 earnings per share. Research analysts expect that CVS Health Co. will post 8.33 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.40%. CVS Health’s dividend payout ratio (DPR) is currently 41.18%.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.